Depression :: Depression, not antidepressants, increases heart failure risk
People who are depressed have an increased risk of dying from heart failure, and a new study by Duke University Medical Center researchers may help explain why.
People who are depressed have an increased risk of dying from heart failure, and a new study by Duke University Medical Center researchers may help explain why.
As the prevalence of allergic rhinitis appears to be rising, there are increasing concerns about its impact on health, sleep, work and school performance, as well as unmet patient needs regarding its treatment according to experts presenting new data at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on allergic asthma.
Working with dogs and using the latest in imaging software and machinery, also known as a 64-slice CT scanner, Johns Hopkins heart specialists have developed a fast and accurate means of tracking blood that has been slowed down by narrowing of the coronary arteries. Researchers say it took them less than half the time of exercise stress tests and echocardiograms currently used to find early warning of vessels more likely to become blocked and cause heart attack.
The science of cancer prevention has advanced to the point where researchers now say they can detect ?cancer genes? in the breath of smokers, and can test the presence of two proteins in men they say will predict development of prostate cancer a decade in advance. All of these novel findings need much more examination, of course, but scientists at the American Association for Cancer Research?s Frontiers in Cancer Prevention Research meeting, say these examples illustrate how it is becoming increasingly possible to use genes and their protein products to help predict and diagnose cancer, as well as choose therapy that offers the most potential for a good result. These researchers will also discuss a test that can pick out patients who have pancreatic cancer – an advance that offers hope the disease can be treated at earlier stages than it is now – and how several unique genes can predict which prostate cancer or lung cancer patients will develop aggressive tumors that need additional treatment. Cancer is a disease of genes, they say, so genes can be employed as a crystal ball to thwart the disease.
The clinical difference is small, but the evidence is in ? waltzing does more than other aerobic exercise (ET) for the health of a patient with chronic heart failure (CHF).
Dancing improves ability to function and quality of life among chronic heart failure patients and may be a good alternative to other aerobic exercises, researchers reported at the American Heart Association’s Scientific Sessions 2006.
Children with risk factors such as high blood pressure, obesity, diabetes and high cholesterol levels already show signs of fatty build-up in their arteries that could lead to heart attack in adulthood, researchers reported at the American Heart Association’s Scientific Sessions 2006.
Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.
New Mayo Clinic research suggests that a shearing injury of the tissue that lines the tendons within the carpal tunnel may cause carpal tunnel syndrome, a debilitating condition of the wrist and hand.